Cost-effectiveness of vedolizumab compared with conventional therapy for ulcerative colitis patients in the UK

OBJECTIVE: To examine the clinical and economic impact of vedolizumab compared with conventional therapy in the treatment of moderately-to-severely active ulcerative colitis (UC) in the UK based on results of the GEMINI I trial. METHODS: A decision-analytic model in Microsoft Excel was used to compa...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clinicoecon Outcomes Res
Main Authors: Wilson, Michele R, Azzabi Zouraq, Ismail, Chevrou-Severac, Helene, Selby, Ross, Kerrigan, Matthew C
Formato: Artigo
Idioma:Inglês
Publicado em: Dove Medical Press 2017
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5652924/
https://ncbi.nlm.nih.gov/pubmed/29081667
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CEOR.S135609
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados